Clinical Application of New Advances in the Treatment of Head and Neck Cancer

Download All
Review the latest data and expert guidance on managing patients with head and neck cancer. This comprehensive program features clinical commentaries, short-form video learning episodes, updates to the online Interactive Decision Support Tool, and downloadable slides.
Aarti Bhatia, MD, MPH
Barbara Burtness, MD
Elisabeth King, RN, FNP, AGN, AOCNP
Cristina P. Rodriguez, MD

Text Modules

In response to the COVID-19 pandemic, my institution has implemented multiple procedures to protect patients and personnel from COVID-19 infection and avoid interruptions in cancer therapy.

Cristina P. Rodriguez, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: July 15, 2020 Expired: No longer available for credit

Immunotherapies have revolutionized the treatment of metastatic recurrent head and neck cancer. In this commentary, I revisit the data behind current best practice and look ahead to new combination therapies.

Barbara Burtness, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: October 8, 2020 Expired: No longer available for credit

Read my commentary to see my approach to patients with head and neck cancer and an NTRK gene fusion.

Aarti Bhatia, MD, MPH Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: November 11, 2020 Expired: No longer available for credit

Read my commentary to see my approach to managing immunotherapy-related adverse events in patients with head and neck cancer.

Elisabeth King, RN, FNP, AGN, AOCNP Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: February 12, 2021 Expired: No longer available for credit

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings